Showing posts with label U.S. Food and Drug Administration. Show all posts
Showing posts with label U.S. Food and Drug Administration. Show all posts
Thursday, November 13, 2025

Trump's Memorandum on Pharma DTC Advertising is a Solution in Search of a Problem

›
By:  Ranier Simons , ADAP Blog Guest Contributor Adding to the growing list of edicts issued by the Trump Administration is a presidential m...
Thursday, August 8, 2024

Fraudsters are Using Grindr to Buy HIV Meds

›
By:  Brandon M. Macsata , CEO, ADAP Advocacy;  Shabbir Imber Safdar , Executive Director, Partnership for Safe Medicines Earlier this year, ...
Thursday, July 4, 2024

Drug Shortages Growing, but Spares HIV-related Injectable Therapies

›
By:  Ranier Simons , ADAP Blog Guest Contributor Periodic shortages of all kinds of products are common. The height of the coronavirus pande...
Thursday, June 13, 2024

What are 'Major Statements' for Direct-to-Consumer Pharmaceutical Advertisements

›
By:  Ranier Simons , ADAP Blog Guest Contributor In the United States, it is common to see advertisements for drugs. Ads appear in print mag...
Thursday, February 29, 2024

Evidence Suggests Long-Acting Injectables Game Changer for Adherence

›
By:  Ranier Simons , ADAP Blog Guest Contributor Adherence to medication is one of the most important tenets of antiretroviral therapy (ART)...
Thursday, January 18, 2024

FDA Failure: Why Agency's Approval of Floridian Drug Importation Plan Fails Patients on Both Sides of the Border

›
By:  Ranier Simons , ADAP Blog Guest Contributor The U.S. Food & Drug Administration (FDA) has started the year off in the news cycle un...
Thursday, September 14, 2023

New Study Dissects Efficacy of Lenacapavir

›
By:  Ranier Simons , ADAP Blog Guest Contributor Lenacapavir, a novel HIV treatment medication, again appears in the medical news cycle. A r...
Thursday, July 13, 2023

Modern Antiretroviral Therapy is Less Toxic, but Not Free from Side Effects

›
By:  Ranier Simons , ADAP Blog Guest Contributor Antiretroviral therapy (ART) has indisputably improved the medical outcomes of people livin...
Thursday, April 20, 2023

Flawed Mifepristone Decision Threatens Public Health

›
By:  Ranier Simons , ADAP Blog Guest Contributor Ideological attacks on evidence-based established medical science through litigation contin...